Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Zynlonta
Zynlonta
ADC Discontinues Zynlonta Trial in DLBCL After Seven Deaths
BioSpace
Fri, 07/21/23 - 10:02 am
ADC Therapeutics
Zynlonta
diffuse large B-cell lymphoma
clinical trials
ADC Therapeutics Halts Enrollment of Zynlonta Trial After Seven Patient Deaths
BioSpace
Tue, 07/11/23 - 11:29 pm
ADC Therapeutics
Zynlonta
clinical trials
patient deaths
diffuse large B-cell lymphoma
ADC Therapeutics strikes a $325M royalty deal to fuel its cancer drug strategy
MedCity News
Fri, 08/27/21 - 10:52 am
ADC Therapeutics
HealthCare Royalty Partners
Zynlonta
large cell B-cell lymphoma
ADC Therapeutics sells off royalty share for lead antibody-drug conjugate in $325M deal
Endpoints
Thu, 08/26/21 - 10:53 am
ADC Therapeutics
Zynlonta
Cami
camidanlumab tesirine
ADC Therapeutics gets the nod from the FDA for its CD19-targeted antibody drug conjugate
Biopharma Reporter
Mon, 04/26/21 - 11:55 am
ADC Therapeutics
Zynlonta
antibody-drug conjugate
FDA
relapsed or refractory diffuse large B-cell lymphoma